Business

Proposed Patent for Ketamine Treatment Challenged by Clinicians

A Salt Lake City doctor claims his method of using high dose intramuscular injections of ketamine is novel, but other ketamine clinicians say it’s not a new discovery.

Field Trip Collaborates with Jamaican University Researchers to Investigate New Psilocybin Therapies

The focus is on how psilocybin-producing mushrooms may generate a different effect than synthetic psilocybin.

North Star Announces Ethical Pledge for Era of Psychedelic Business

It’s time for the psychedelic community to set high standards, say the cofounders in this exclusive video interview.

Anticipating a $10 Million Shortfall Burning Man Asks Ticket Holders and Participants To Donate

After canceling its main event, Burning Man is facing a $10 million budget shortfall for 2020 and appealing to its community for donations.

Researchers Examine Psilocybin Patent Claims

A patent granted to Compass Pathways is drawing attention to how pharmaceutical companies might end up owning forms of long-established psychedelic substances. Part 2 of a 3-part series.

Challenges to a Company’s Psilocybin Patent Highlight Contrasting Business Strategies for Developers of Psychedelic Therapies

Tactics used by Compass Pathways common to pharma companies pose ethical questions for the emerging psychedelics industry. Part one of a three-part series.